Literature DB >> 29989522

Importance of Long-term Low-Dose CT Follow-up after Negative Findings at Previous Lung Cancer Screening.

John Kavanagh1, Geoffrey Liu1, Ravi Menezes1, Grainne M O'Kane1, Maureen McGregor1, Ming Tsao1, Frances A Shepherd1, Heidi Schmidt1.   

Abstract

Purpose To assess the incidence of lung cancer in a cohort of patients with negative findings at previous lung cancer screening. Materials and Methods In this prospective cohort study, the authors first identified 4782 individuals who had negative screening results as part of the International Early Lung Cancer Action Program (1993-2005). Subjects were assigned a lung cancer risk score by using a validated risk model. Starting with those at highest risk, subjects were interviewed by phone and invited to undergo low-dose CT between March 2013 and October 2016. Subjects with a diagnosis of lung cancer and those who had died of lung cancer were determined. Descriptive statistics were used to summarize data. The independent samples t test and Fisher exact test were used to compare age, sex, and risk scores. Results A total of 327 study participants were contacted, and 200 subjects participated in this study. The average age was 74 years (range, 57-88 years), and the median time since previous CT was 7 years. The incidence rate of developing lung cancer during the next 6 years was estimated at 5.6%. The period prevalence of lung cancer was 20.8% (new and preexisting lung cancer, 68 of total cohort of 327). The detection rate of low-dose CT was 7% (14 of 200 subjects). Of the 14 screening-detected cancers, 12 were stage I or II. Conclusion High-risk individuals have a high incidence of lung cancer after previous negative lung cancer screening. Early-stage lung cancer can be successfully detected in older high-risk individuals. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 29989522     DOI: 10.1148/radiol.2018180053

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.

Authors:  Hilary A Robbins; Christine D Berg; Li C Cheung; Anil K Chaturvedi; Hormuzd A Katki
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

2.  Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.

Authors:  Roger Y Kim; Katharine A Rendle; Nandita Mitra; Chelsea A Saia; Christine Neslund-Dudas; Robert T Greenlee; Andrea N Burnett-Hartman; Stacey A Honda; Michael J Simoff; Marilyn M Schapira; Jennifer M Croswell; Rafael Meza; Debra P Ritzwoller; Anil Vachani
Journal:  Ann Am Thorac Soc       Date:  2022-09

3.  Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.

Authors:  Jacqueline V Aredo; Eunji Choi; Victoria Y Ding; Martin C Tammemägi; Kevin Ten Haaf; Sophia J Luo; Neal D Freedman; Lynne R Wilkens; Loïc Le Marchand; Heather A Wakelee; Rafael Meza; Sung-Shim Lani Park; Iona Cheng; Summer S Han
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

Review 4.  Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe.

Authors:  Giulia Veronesi; David R Baldwin; Claudia I Henschke; Simone Ghislandi; Sergio Iavicoli; Matthijs Oudkerk; Harry J De Koning; Joseph Shemesh; John K Field; Javier J Zulueta; Denis Horgan; Lucia Fiestas Navarrete; Maurizio Valentino Infante; Pierluigi Novellis; Rachael L Murray; Nir Peled; Cristiano Rampinelli; Gaetano Rocco; Witold Rzyman; Giorgio Vittorio Scagliotti; Martin C Tammemagi; Luca Bertolaccini; Natthaya Triphuridet; Rowena Yip; Alexia Rossi; Suresh Senan; Giuseppe Ferrante; Kate Brain; Carlijn van der Aalst; Lorenzo Bonomo; Dario Consonni; Jan P Van Meerbeeck; Patrick Maisonneuve; Silvia Novello; Anand Devaraj; Zaigham Saghir; Giuseppe Pelosi
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

5.  Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.

Authors:  Martin C Tammemägi; Kevin Ten Haaf; Iakovos Toumazis; Chung Yin Kong; Summer S Han; Jihyoun Jeon; John Commins; Thomas Riley; Rafael Meza
Journal:  JAMA Netw Open       Date:  2019-03-01

6.  Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.

Authors:  Rudolf M Huber; Milena Cavic; Anna Kerpel-Fronius; Lucia Viola; John Field; Long Jiang; Ella A Kazerooni; Coenraad F N Koegelenberg; Anant Mohan; Ricardo Sales Dos Santos; Luigi Ventura; Murry Wynes; Dawei Yang; Javier Zulueta; Choon-Taek Lee; Martin C Tammemägi; Claudia I Henschke; Stephen Lam
Journal:  J Thorac Oncol       Date:  2021-12-03       Impact factor: 15.609

7.  Small-sized Pulmonary Adenocarcinoma Manifesting Skip-like Transition from Nonsolid Nodule: A Case Report.

Authors:  Takaomi Hanaoka; Naoki Ishizaka; Dai Kimura; Kayoko Ikegawa; Mitsuyo Okada; Shugo Takahata; Hiroaki Motoyama
Journal:  JMA J       Date:  2022-05-30

8.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.